Transasia Bio-Medicals Limited - Company Profile

It is a healthcare public limited company based in Mumbai, Maharashtra, India, established in 1985.
1985 Mumbai, Maharashtra, India Active
Last Updated:
About Transasia Bio-Medicals Limited

Transasia Bio-Medicals Limited, a active public limited company, was established on 10 May 1985 in Mumbai, Maharashtra, India. Engaging in medical & laboratory equipment within the manufacturing sector, it holds CIN: U33110MH1985PLC036198. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹4.40 Cr and a paid-up capital of ₹4.00 Cr.

It upholds a compliant status. Employing 1,270 professional, Its leadership includes Sunil Hassanand Vazirani (Whole-Time Director), Suresh Hassanand Vazirani (Director), Mala Suresh Vazirani (Director). Past directors included Ravi Hassanand Vazirani, Suresh Hassanand Vazirani, Mala Suresh Vazirani. It holds ₹108.00 Cr open charges and ₹999.70 Cr settled loans. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at Transasia House, 8, Chandivali Studio Road,, Mumbai, Maharashtra, 400072.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U33110MH1985PLC036198

  • Registration Number

    036198

  • Incorporation Date

    10 May 1985

  • Authorized Capital

    ₹4.40 Cr

  • Paid-Up Capital

    ₹4.00 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 4.40 Cr
  • Paid Up Capital ₹ 4.00 Cr
  • Company Age 40 Year, 9 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 108.00 Cr
  • Satisfied Charges ₹ 999.70 Cr
  • Revenue Growth **** 23.51%
  • Profit Growth **** 362.81%
  • Ebitda **** 41.32%
  • Net Worth -9.90%
  • Total Assets -6.18%
Company report

Transasia Bio-Medicals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Transasia Bio-Medicals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Transasia Bio-Medicals Limited?
Current Directors
Name Designation Appointment Date Status
Sunil Hassanand Vazirani Whole-Time Director 01 May 2024 Current
Suresh Hassanand Vazirani Director 01 Apr 2008 Current
Mala Suresh Vazirani Director 03 Dec 2010 Current
Rajendra Vadilal Gandhi Additional Director 18 Jun 2025 Current
Sanjay Surinder Arora Director 30 Dec 2024 Current
Vibhuti Suresh Vazirani Director 01 Mar 2022 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 30 Sep 2018 Past
Pramod Abcsdd Managing Director 01 Mar 2022 Past
Pramod Abcsdd Director 01 Apr 2008 Past
Pramod Abcsdd Additional Director 24 Dec 2016 Past
Pramod Abcsdd Additional Director 30 Mar 2015 Past
Pramod Abcsdd Additional Director 30 Mar 2015 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Transasia Bio-Medicals.

Transasia Bio-Medicals Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 23.51% increase. The company also saw a substantial improvement in profitability, with a 362.81% increase in profit. The company's net worth dipped by a decrease of 9.9%.

Transasia Bio-Medicals revenue growth over time
Transasia Bio-Medicals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
23.51%
*******
*******
*******
*******
Revenue from Operations
*******
38.02%
*******
*******
*******
*******
Total Assets
*******
-6.18%
*******
*******
*******
*******
Profit or Loss
*******
362.81%
*******
*******
*******
*******
Net Worth
*******
-9.90%
*******
*******
*******
*******
EBITDA
*******
41.32%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Transasia Bio-Medicals?

In 2022, Transasia Bio-Medicals had a promoter holding of 100.00%. The company had 2 Subsidiaries and 1 Joint Venture. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹1,080,000,000.00

Satisfied Charges

₹9,997,038,909.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 42.00 Cr
  • Citi Bank N.A. : 30.00 Cr
  • The Hongkong And Shanghai Banking Corporation Limited : 20.00 Cr
  • The Royal Bank Of Scotland N V : 16.00 Cr
Latest Charge Details
Date Lender Amount Status
23 Jul 2018 The Hongkong And Shanghai Banking Corporation Limited ₹20.00 Cr Open
21 May 2014 Citi Bank N.A. ₹30.00 Cr Open
07 Sep 2007 Hdfc Bank Limited ₹42.00 Cr Open
30 Apr 2007 The Royal Bank Of Scotland N V ₹16.00 Cr Open
12 Jun 2019 The Hongkong And Shanghai Banking Corporation Limited ₹109.84 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Transasia Bio-Medicals?

Transasia Bio-Medicals has a workforce of 1270 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Transasia Bio-Medicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Transasia Bio-Medicals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Transasia Bio-Medicals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Transasia Bio-Medicals Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was documented.

  • Director Appointment

    Shiraz Bugwadia Homi was appointed as a Director was appointed as a Director on 29 Sep 2025 & has been associated with this company since 5 months . was recorded as a recent event.

  • Director Appointment

    The activity Aditi Pradeep Pai was appointed as a Cfo was appointed as a Cfo on 15 Jul 2025 & has been associated with this company since 7 months 15 days . was completed.

  • Director Appointment

    Progress on Rajendra Vadilal Gandhi was appointed as a Additional Director was appointed as a Additional Director on 18 Jun 2025 & has been associated with this company since 8 months 11 days . was documented.

  • Balance Sheet

    Progress on Transasia Bio-Medicals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.

  • Director Appointment

    Sanjay Surinder Arora was appointed as a Director was appointed as a Director on 30 Dec 2024 & has been associated with this company since 1 year 2 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Recent News, Updates & Announcement

Explore news and more updates - View Recent News

Frequently Asked Questions
What is the CIN of Transasia Bio-Medicals Limited?

The CIN of Transasia Bio-Medicals Limited is U33110MH1985PLC036198.

Where is Transasia Bio-Medicals Limited headquartered?

Transasia Bio-Medicals Limited is headquartered at Transasia House, 8, Chandivali Studio Road,, Mumbai, Maharashtra, 400072.

When was Transasia Bio-Medicals Limited incorporated?

Transasia Bio-Medicals Limited was incorporated on 10 May 1985.

Who are the current directors of Transasia Bio-Medicals Limited?
What is the primary industry of Transasia Bio-Medicals Limited?

The primary industry of Transasia Bio-Medicals Limited is Manufacturing.

Is Transasia Bio-Medicals Limited a listed company?

Transasia Bio-Medicals Limited is unlisted.

What is the capital structure of Transasia Bio-Medicals Limited?

The authorized capital of Transasia Bio-Medicals Limited is ₹4.40 Cr, and the paid-up capital is ₹4.00 Cr.

What is the compliance status of Transasia Bio-Medicals Limited?

The compliance status of Transasia Bio-Medicals Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available